Jones Financial Companies’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
6,016
+2,035
| +51% | +$898K | ﹤0.01% | 683 |
|
|
2025
Q1 | $1.96M | Buy |
3,981
+1,513
| +61% | +$745K | ﹤0.01% | 658 |
|
|
2024
Q4 | $994K | Buy |
2,468
+1,062
| +76% | +$428K | ﹤0.01% | 749 |
|
|
2024
Q3 | $651K | Buy |
1,406
+808
| +135% | +$374K | ﹤0.01% | 728 |
|
|
2024
Q2 | $280K | Buy |
598
+583
| +3,887% | +$273K | ﹤0.01% | 727 |
|
|
2024
Q1 | $6.27K | Buy |
15
+9
| +150% | +$3.76K | ﹤0.01% | 1141 |
|
|
2023
Q4 | $2.44K | Buy |
+6
| New | +$2.44K | ﹤0.01% | 885 |
|
|
2023
Q1 | – | Sell |
-8
| Closed | -$2K | – | 786 |
|
|
2022
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 622 |
|
|
2022
Q3 | – | Sell |
-4
| Closed | -$1K | – | 740 |
|
|
2022
Q2 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 694 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | -$3K | – | 848 |
|
|
2021
Q4 | $3K | Hold |
13
| – | – | ﹤0.01% | 705 |
|
|
2021
Q3 | $2K | Hold |
13
| – | – | ﹤0.01% | 627 |
|
|
2021
Q2 | $3K | Sell |
13
-16
| -55% | -$3.69K | ﹤0.01% | 600 |
|
|
2021
Q1 | $6K | Sell |
29
-104
| -78% | -$21.5K | ﹤0.01% | 607 |
|
|
2020
Q4 | $31K | Buy |
+133
| New | +$31K | ﹤0.01% | 332 |
|
|
2013
Q4 | – | Sell |
-26
| Closed | -$2K | – | 538 |
|
|
2013
Q3 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 659 |
|